Background—Limited information exists on the intermediate-term graft patency and 5-year
clinical outcomes of patients receiving saphenous vein grafts with multiple (m-SVG) versus …

Objectives: Coronary artery bypass grafting (CABG) success is reduced by graft occlusion.
Understanding factors associated with graft occlusion may improve patient outcomes. The …

We read with interest the article 1 entitled “C-Reactive Protein to Albumin Ratio in Patients
With Saphenous Vein Graft Disease”. We congratulate the authors 1 for their contribution …

OBJECTIVES Saphenous vein graft (SVG) remains the predominant conduit used in
coronary surgery. The internal mammary artery has higher later term patency and confers …

Coronary bypass graft surgery provides symptomatic relief and a long life expectancy for
most patients with coronary artery disease who have suitable vessels. Although arterial …

Background—Coronary artery bypass grafting success is limited by vein graft failure (VGF).
Understanding the factors associated with VGF may improve patient outcomes. Methods and …

Introduction: There have been several attempts to overcome the poor graft patency of
saphenous vein grafts.“No-touch” saphenous vein graft (NT-SVG) could be a solution to …

Up to 20% of saphenous vein grafts (SVGs) fail within 2 years of coronary artery bypass
grafting (CABG). The long-term effects of early SVG failure on major clinical events remain …

We investigated the association between the preoperative logistic clinical syntax score (log
CSS), saphenous vein graft (SVG) patency, and major adverse cardiac and cerebrovascular …

We have read the article by Sandner et al. with great interest. The authors have undertaken
a post hoc analysis of the VEST III Trial to examine the impact of open versus endoscopic …